Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Brings to Portola 20 Years of Clinical Development and Approval Experience
SOUTH SAN FRANCISCO, Calif., Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the appointment of Rajiv... Biopharmaceuticals, Personnel Portola Pharmaceuticals, Andexxa, coagulation factor Xa, Bevyxxa, betrixaban
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Marketing | Pharmaceuticals